Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD)

NCT00396604 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive
COPD
Lung Diseases, Obstructive

Interventions

DRUG: indacaterol maleate

Sponsor

Novartis